In less than 90 minutes, a new, less invasive electrical stimulation technique has been found to improve breathing in people with sleep apnea. The technique, which involves percutaneous hypoglossal ...

By Hugo Francisco de Souza New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Left untreated, obstructive sleep apnea (OSA) can have short- and long-term effects on your brain, from memory and learning to cognitive functions.

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...

We're all chasing better rest. From herbal teas and nighttime routines to white noise machines and tracking apps, quality sleep is now a key part of the wellness conversation. But for people with ...

These sleep trackers claim to be able to detect breathing irregularities as you sleep – so how did they fare when I challenged them to sniff out my diagnosed disorder?

A new study finds that having obstructive sleep apnea increases the risk that a person will eventually develop Parkinson’s disease, and the more severe the apnea, the higher the risk. CPAP therapy ...

Over half of newborns with severe spina bifida experience sleep-disordered breathing, an often overlooked early threat to ...